Statins and Multiple Noncardiovascular Outcomes

@article{He2018StatinsAM,
  title={Statins and Multiple Noncardiovascular Outcomes},
  author={Yazhou He and Xue Li and Danijela Gasevic and Eleanor Brunt and Fiona McLachlan and Marisa E. Millenson and Maria Timofeeva and John P. A. Ioannidis and Harry Campbell and Evropi Theodoratou},
  journal={Annals of Internal Medicine},
  year={2018},
  volume={169},
  pages={543-553}
}
  • Yazhou He, Xue Li, +7 authors Evropi Theodoratou
  • Published 2018
  • Medicine
  • Annals of Internal Medicine
  • Statins were first approved for prescription use in the United States in 1987 (1). Since their introduction, they have been widely used for reducing cardiac morbidity and mortality in both the primary and secondary prevention of cardiovascular disease (CVD) (2, 3). An estimated 38.6 million persons in the United States (around 12% of the population) were using statins in 2011 to 2012 (4), and recent guidelines have pushed for wider use (5). Because of the worldwide increase in statin use in the… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 12 CITATIONS

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 90 REFERENCES